女阴硬化性苔藓诊疗专家共识

doi:10.35541/cjd.20201202

Abstract

Abstract: 【Abstract】 Vulvar lichen sclerosus （VLS） is a recurrent chronic inflammatory disease that can occur in women of almost all ages, especially menopausal, perimenopausal and prepubertal women. The typical skin lesions include ivory-/porcelain-white sclerotic atrophic plaques, and anatomical distortion of the vulva, urethra and anus in the late stage, which can lead to difficulties in sexual activities, urination and defecation. The Dermatology Branch of China International Exchange and Promotion Association for Medical and Healthcare organized several Chinese experts to develop this Chinese expert consensus on the diagnosis and treatment of VLS, based on clinical researches and guidelines for the diagnosis and treatment of VLS in China and other countries as well as experience and perspectives of Chinese experts.

Key words: Vulvar lichen sclerosus, Diagnosis, Treatment, Consensus

Dermatology Branch of China International Exchange and Promotion Association for Medical and Healthcare. Expert consensus on the diagnosis and treatment of vulvar lichen sclerosus[J].Chinese Journal of Dermatology, 2021, 54(5): 371-375.

References ［39］

［1］	Goldstein AT, Marinoff SC, Christopher K, et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice［J］. J Reprod Med, 2005,50（7）:477⁃480.
［2］	文玮, 杨敏, 韩玉, 等. 129例女阴硬化性苔藓临床特征分析［J］. 中华皮肤科杂志, 2018,51（4）:283⁃287. doi: 10.3760/cma.j.issn.0412⁃4030.2018.04.009.
［3］	Marfatia Y, Surani A, Baxi R. Genital lichen sclerosus et atrophicus in females: an update［J］. Indian J Sex Transm Dis AIDS, 2019,40（1）:6⁃12. doi: 10.4103/ijstd.IJSTD_23_19.
［4］	Lee A, Bradford J, Fischer G. Long⁃term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women［J］. JAMA Dermatol, 2015,151（10）:1061⁃1067. doi: 10.1001/jamadermatol.2015.0643.
［5］	Kohn JR, Connors TM, Chan W, et al. Clinical outcomes and adherence to topical corticosteroid therapy in women with vulvar lichen sclerosus: a retrospective cohort study［J］. J Am Acad Dermatol, 2020,83（4）:1104⁃1109. doi: 10.1016/j.jaad.2020.05. 006.
［6］	Melnick LE, Steuer AB, Bieber AK, et al. Lichen sclerosus among women in the United States［J］. Int J Womens Dermatol, 2020,6（4）:260⁃262. doi: 10.1016/j.ijwd.2020.05.001.
［7］	杨敏, 鲍迎秋, 高小曼, 等. 女阴硬化性苔藓99例临床分析［J］. 中国皮肤性病学杂志, 2018,32（7）:780⁃783. doi: 10.13735/j.cjdv.1001⁃7089.201712079.
［8］	Tong LX, Sun GS, Teng JM. Pediatric lichen sclerosus: a review of the epidemiology and treatment options［J］. Pediatr Dermatol, 2015,32（5）:593⁃599. doi: 10.1111/pde.12615.
［9］	Trokoudes D, Lewis FM. Lichen sclerosus ⁃ the course during pregnancy and effect on delivery［J］. J Eur Acad Dermatol Venereol, 2019,33（12）:e466⁃e468. doi: 10.1111/jdv.15788.
［10］	Singh N, Ghatage P. Etiology, clinical features, and diagnosis of vulvar lichen sclerosus: a scoping review［J］. Obstet Gynecol Int, 2020,2020:7480754. doi: 10.1155/2020/7480754.
［11］	Xavier J, Vieira⁃Baptista P, Moreira A, et al. Vaginal lichen sclerosus: report of two cases［J］. Facts Views Vis Obgyn, 2017,9（3）:171⁃173.
［12］	Gadaldi K, Cazzaniga S, Feldmeyer L, et al. Genital lichen sclerosus in women: a histopathological analysis of 38 criteria［J］. J Eur Acad Dermatol Venereol, 2020,34（8）:e418⁃e420. doi: 10.1111/jdv.16368.
［13］	Borghi A, Corazza M, Minghetti S, et al. Dermoscopic features of vulvar lichen sclerosus in the setting of a prospective cohort of patients: new observations［J］. Dermatology, 2016,232（1）:71⁃77. doi: 10.1159/000439198.
［14］	罗毅鑫, 刘洁, 池诚, 等. 外阴硬化性苔藓的皮肤镜特征分析［J］. 中华皮肤科杂志, 2018,51（11）:809⁃811. doi: 10.3760/cma.j.issn.0412⁃4030.2018.11.007.
［15］	Bleeker MC, Visser PJ, Overbeek LI, et al. Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma［J］. Cancer Epidemiol Biomarkers Prev, 2016,25（8）:1224⁃1230. doi: 10.1158/1055⁃9965.EPI⁃16⁃0019.
［16］	Dell EA, Miest R, Lohse CM, et al. Vulvar neoplasms in 275 women with genital lichen sclerosus and impact of treatment: a retrospective chart review［J］. J Eur Acad Dermatol Venereol, 2018,32（9）:e363⁃e365. doi: 10.1111/jdv.14938.
［17］	Virgili A, Minghetti S, Borghi A, et al. Long⁃term maintenance therapy for vulvar lichen sclerosus: the results of a randomized study comparing topical vitamin E with an emollient［J］. Eur J Dermatol, 2013,23（2）:189⁃194. doi: 10.1684/ejd.2013.1987.
［18］	Kai A, Lewis F. Long⁃term use of an ultrapotent topical steroid for the treatment of vulval lichen sclerosus is safe［J］. J Obstet Gynaecol, 2016,36（2）:276⁃277. doi: 10.3109/01443615.2015. 1049252.
［19］	van der Meijden WI, Boffa MJ, Ter Harmsel WA, et al. 2016 European guideline for the management of vulval conditions［J］. J Eur Acad Dermatol Venereol, 2017,31（6）:925⁃941. doi: 10. 1111/jdv.14096.
［20］	Corazza M, Virgili A, Toni G, et al. Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment?［J］. J Dermatolog Treat, 2018,29（3）:305⁃309. doi: 10.1080/09546634. 2017.1360990.
［21］	Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018［J］. Br J Dermatol, 2018,178（4）:839⁃853. doi: 10.1111/bjd.16241.
［22］	Lee A, Fischer G. Diagnosis and treatment of vulvar lichen sclerosus: an update for dermatologists［J］. Am J Clin Dermatol, 2018,19（5）:695⁃706. doi: 10.1007/s40257⁃018⁃0364⁃7.
［23］	Murina F, Rehman S, Di Francesco S, et al. Vulvar lichen sclerosus: a comparison of the short⁃term topical application of clobetasol dipropionate 0.05% versus mometasone furoate 0.1%［J］. J Low Genit Tract Dis, 2015,19（2）:149⁃151. doi: 10.1097/LGT.0000000000000065.
［24］	Kirtschig G, Becker K, Günthert A, et al. Evidence⁃based （S3） guideline on （anogenital） lichen sclerosus［J］. J Eur Acad Dermatol Venereol, 2015,29（10）:e1⁃e43. doi: 10.1111/jdv.13136.
［25］	Corazza M, Borghi A, Minghetti S, et al. Clobetasol propionate vs. mometasone furoate in 1⁃year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial［J］. J Eur Acad Dermatol Venereol, 2016,30（6）:956⁃961. doi: 10. 1111/jdv.13166.
［26］	陈伟, 李珊山. 外阴硬化性苔藓67例临床分析［J］. 中国皮肤性病学杂志, 2017,31（4）:398⁃399. doi: 10.13735/j.cjdv.1001⁃7089.201609036.
［27］	Anderson K, Ascanio NM, Kinney MA, et al. A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor［J］. J Dermatolog Treat, 2016,27（1）:64⁃66. doi: 10.3109/09546634.2015.1054777.
［28］	Mazzilli S, Diluvio L, Di Prete M, et al. Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review［J］. J Int Med Res, 2018,46（9）:3724⁃3728. doi: 10.1177/0300060518778219.
［29］	Funaro D, Lovett A, Leroux N, et al. A double⁃blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus［J］. J Am Acad Dermatol, 2014,71（1）:84⁃91. doi: 10.1016/j.jaad.2014.02.019.
［30］	Prodromidou A, Chatziioannou E, Daskalakis G, et al. Photodynamic therapy for vulvar lichen sclerosus⁃a systematic review［J］. J Low Genit Tract Dis, 2018,22（1）:58⁃65. doi: 10.1097/LGT.0000000000000362.
［31］	Shi L, Miao F, Zhang LL, et al. Comparison of 5⁃aminolevulinic acid photodynamic therapy and clobetasol propionate in treatment of vulvar lichen sclerosus［J］. Acta Derm Venereol, 2016,96（5）:684⁃688. doi: 10.2340/00015555⁃2341.
［32］	陈静, 李振鲁, 朱雪峰, 等. 氨基酮戊酸光动力疗法治疗硬化萎缩性苔藓的疗效观察［J］. 中华皮肤科杂志, 2014,47（6）:433⁃434. doi: 10.3760/cma.j.issn.0412⁃4030.2014.06.020.
［33］	赵慧霞, 贾振宇, 张嘉, 等. 盐酸氨酮戊酸光动力治疗外阴硬化性苔藓的疗效观察［J］. 中国现代医学杂志, 2018,28（28）:113⁃116. doi: 10.3969/j.issn.1005⁃8982.2018.28.020.
［34］	Mallidi S, Anbil S, Bulin AL, et al. Beyond the barriers of light penetration: strategies, perspectives and possibilities for photodynamic therapy［J］. Theranostics, 2016,6（13）:2458⁃2487. doi: 10.7150/thno.16183.
［35］	Declercq A, Güvenç C, De Haes P. Proposition of standardized protocol for photodynamic therapy for vulvar lichen sclerosus［J］. J Dermatolog Treat, 2020. doi: 10.1080/09546634.2020. 1771260.［published online ahead of print 2020⁃07⁃01］.
［36］	Krapf JM, Mitchell L, Holton MA, et al. Vulvar lichen sclerosus: current perspectives［J］. Int J Womens Health, 2020,12:11⁃20. doi: 10.2147/IJWH.S191200.
［37］	Pérez⁃López FR, Vieira⁃Baptista P. Lichen sclerosus in women: a review［J］. Climacteric, 2017,20（4）:339⁃347. doi: 10.1080/13697137.2017.1343295.
［38］	Nguyen Y, Bradford J, Fischer G. Lichen sclerosus in pregnancy: a review of 33 cases［J］. Aust N Z J Obstet Gynaecol, 2018,58（6）:686⁃689. doi: 10.1111/ajo.12812.
［39］	李静然, 魏丽惠. 外阴苔藓类疾病的局部糖皮质激素治疗［J］. 中华妇产科杂志, 2018,53（9）:651⁃653. doi: 10.3760/cma.j.issn.0529⁃567x.2018.09.016.

[1]	Committee on Autoimmune Diseases, China Dermatologist Association. Expert consensus on methotrexate in the treatment of immune-associated dermatoses [J]. Chinese Journal of Dermatology, 2021, 54(5): 382-390.
[2]	Committee on Allergic Diseases, China Dermatologist Association, Atopic Dermatitis Research Center, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotion Association for Medical and Healthcare. Expert consensus for management of itch in atopic dermatitis [J]. Chinese Journal of Dermatology, 2021, 54(5): 391-396.
[3]	Adverse Drug Reaction Research Center of Chinese Society of Dermatology. Expert consensus on the diagnosis and treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2021, 54(5): 376-381.
[4]	Bi Tiantian, Guan Zhiwei, Liu Xinxin, Li Qinfeng. Application of reflectance confocal microscopy in the diagnosis and treatment of childhood scabies [J]. Chinese Journal of Dermatology, 2021, 54(5): 433-435.
[5]	Zheng Yujie, Yang Haiqiong, Cui Hongyan. Dermoscopic features of 82 cases of molluscum contagiosum [J]. Chinese Journal of Dermatology, 2021, 54(5): 428-430.
[6]	Li Ke, Wang Qianqiu, Long Fuquan. Risk factors and predictors of neurosyphilis [J]. Chinese Journal of Dermatology, 2021, 54(5): 459-462.
[7]	Li Yan, Xu Wei, Li Linfeng. Efficacy of topical hydrocortisone butyrate cream combined with a skin cream dressing in the treatment of atopic dermatitis: a randomized, open, controlled clinical study [J]. Chinese Journal of Dermatology, 2021, 54(5): 452-455.
[8]	Hu Yanyan, Jiang Qian, Chen Liuqing, Li Dongsheng. Application of reflectance confocal microscopy in the evaluation of clinical efficacy of hemoporfin-mediated photodynamic therapy for purple-type port-wine stain [J]. Chinese Journal of Dermatology, 2021, 54(4): 342-346.
[9]	Wang Yanqing, Guo Ying. Pathological features and diagnosis of Spitz nevus [J]. Chinese Journal of Dermatology, 2021, 54(4): 308-312.
[10]	Rosacea Research Center, Chinese Society of Dermatology, Rosacea Professional Committee, Chinese Dermatologist Association. Guidelines for the diagnosis and treatment of rosacea in China （2021 edition） [J]. Chinese Journal of Dermatology, 2021, 54(4): 279-288.
[11]	Yi Xiaoqing, Luo Shuaihantian, Zhang Guiying, Lu Qianjin. Diagnosis and treatment of adult-onset Still′s disease [J]. Chinese Journal of Dermatology, 2021, 54(2): 165-169.
[12]	Xie Bo, Wei Xiaodong, Xu Ai′e, Lin Fuquan, Zhou Miaoni. Efficacy of systemic glucocorticoid treatment and its related factors in patients with progressive vitiligo [J]. Chinese Journal of Dermatology, 2021, 54(2): 139-144.
[13]	Pigmentary Disorder Group, Combination of Traditional and Western Medicine Dermatology. Consensus on the diagnosis and treatment of vitiligo （2021 version） [J]. Chinese Journal of Dermatology, 2021, 54(2): 105-109.
[14]	Pigmentary Disorder Group, Combination of Traditional and Western Medicine Dermatology, Research Center for Vitiligo, Chinese Society of Dermatology, Working Group on Pigmentary Disorders, China Dermatologist Association. Consensus on diagnosis and treatment of melasma in China （2021 version） [J]. Chinese Journal of Dermatology, 2021, 54(2): 110-115.
[15]	Consensus Writing Group on the Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in China. Diagnosis and treatment of acne inversa/hidradenitis suppurativa in China: an expert consensus statement （2021 version） [J]. Chinese Journal of Dermatology, 2021, 54(2): 97-104.

Expert consensus on the diagnosis and treatment of vulvar lichen sclerosus

PDF

Like

Knowledge

Abstract

Cite this article

share this article

References ［39］

Related Articles 15

Metrics

Comments

Recommended 10